Zylox-Tonbridge Medical Technology Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Jonathon Zhao
Chief executive officer
CN¥21.2m
Total compensation
| CEO salary percentage | 14.2% |
| CEO tenure | 11.5yrs |
| CEO ownership | 12.7% |
| Management average tenure | no data |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Shares May Have Run Too Fast Too Soon
Apr 23
Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Could Be 48% Below Their Intrinsic Value Estimate
Jan 18Does This Valuation Of Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Imply Investors Are Overpaying?
Sep 21There's Reason For Concern Over Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) Price
Aug 03We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jun 30Is Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Trading At A 45% Discount?
Mar 08We're Not Very Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Rate
Jan 19Here's Why We're Not Too Worried About Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Jul 06We're Hopeful That Zylox-Tonbridge Medical Technology (HKG:2190) Will Use Its Cash Wisely
Jan 27Here's Why We're Not At All Concerned With Zylox-Tonbridge Medical Technology's (HKG:2190) Cash Burn Situation
Oct 05CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -CN¥79m |
| Sep 30 2023 | n/a | n/a | -CN¥101m |
| Jun 30 2023 | n/a | n/a | -CN¥124m |
| Mar 31 2023 | n/a | n/a | -CN¥119m |
| Dec 31 2022 | CN¥21m | CN¥3m | -CN¥114m |
| Sep 30 2022 | n/a | n/a | -CN¥135m |
| Jun 30 2022 | n/a | n/a | -CN¥155m |
| Mar 31 2022 | n/a | n/a | -CN¥178m |
| Dec 31 2021 | CN¥16m | CN¥2m | -CN¥200m |
| Sep 30 2021 | n/a | n/a | -CN¥168m |
| Jun 30 2021 | n/a | n/a | -CN¥135m |
| Mar 31 2021 | n/a | n/a | -CN¥118m |
| Dec 31 2020 | CN¥10m | CN¥1m | -CN¥100m |
| Dec 31 2019 | CN¥1m | CN¥746k | -CN¥67m |
Compensation vs Market: Jonathon's total compensation ($USD2.93M) is above average for companies of similar size in the Hong Kong market ($USD420.26K).
Compensation vs Earnings: Jonathon's compensation has increased whilst the company is unprofitable.
CEO
Jonathon Zhao (55 yo)
11.5yrs
Tenure
CN¥21,179,000
Compensation
Dr. Zhong Zhao also known as Jonathon, serves as Director of Avinger, Inc. since March 04, 2024. He is Founder of Zylox-Tonbridge Medical Technology Co., Ltd. and serves as its Chairman since November 06,...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 11.5yrs | CN¥21.18m | 12.66% CN¥ 442.6m | |
| Senior VP of Sales & Marketing and Executive Director | 6.2yrs | CN¥9.14m | 4.35% CN¥ 152.2m | |
| Senior VP | 5.3yrs | CN¥16.96m | 1.52% CN¥ 53.2m | |
| Independent Non-Executive Director | 3.2yrs | CN¥200.00k | no data | |
| Non-Executive Director | 3.4yrs | no data | no data | |
| Independent Non-Executive Director | 3.2yrs | CN¥200.00k | no data | |
| Non-Executive Director | 3.6yrs | no data | no data | |
| Non Executive Director | 2yrs | no data | no data | |
| Independent Non-Executive Director | 3.2yrs | CN¥200.00k | no data | |
| Employee Supervisor | 3.2yrs | no data | no data | |
| Supervisor | 2yrs | no data | no data | |
| Chairman of the Board of Supervisors | less than a year | no data | no data |
3.2yrs
Average Tenure
50.5yo
Average Age
Experienced Board: 2190's board of directors are considered experienced (3.2 years average tenure).